Pituitary-adrenal suppression in preterm, very low birth weight infants after inhaled fluticasone propionate treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 7, 1998, Pages 2390-2393

  Ng, P C ^a   Fok, T F ^c   Wong, G W K ^c   Lam, C W K ^a   Lee, C H ^c   Wong, M Y ^b   Lam, K ^c   Ma, K C ^c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c Prince of Wales Hospital ^*

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; FLUTICASONE PROPIONATE; HYDROCORTISONE; LUNG SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOCRINE DISEASE; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; INFANT; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; VERY LOW BIRTH WEIGHT;

EID: 0031785885     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.7.4947     Document Type: Article

References (25)

1. Crowley PA. 1995 Antenatal corticosteroid therapy: a meta-analysis of the randomized trials, 1972 to 1994. Am J Obstet Gynecol. 173:322-335.
2. Sinclair JC. 1995 Meta-analysis of randomized controlled trials of antenatal corticosteroid for the prevention of respiratory distress syndrome: discussion. Am J Obstet Gynecol. 173:335-344.
3. Ng PC. 1993 The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child. 68:330-336.
4. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. 1990 Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double blind controlled study. J Pediatr. 117:273-282.
5. Yeh TF, Lin YJ, Hsieh WS, et al. 1997 Early postnatal dexamethasone therapy for the prevention of chronic lung diseases in preterm infants with respiratory distress syndrome: a multicenter clinical trail. Pediatrics. 100(4). URL: http:// www.pediatrics.org/cgi/content/full/100/4/e3.
6. Harding SM. 1990 The human pharmacology of fluticasone propionate. Respir Med. 84(Suppl A):25-29.
7. Fok TF, Dolovich M, Gray S, et al. 1996 Efficiency of aerosol medication delivery from a metered dose inhaler vs. jet nebuliser in infants with bronchopulmonary dysplasia. Pediatr Pulmonol. 21:301-309.
8. Ng PC, Wong GWK, Lam CWK, et al. 1997 The pituitary-adrenal responses to exogenous human corticotropin-releasing hormone in preterm, very low birth weight infants. J Clin Endocrinol Metab. 82:797-799.
9. Hawthorne AB, Record CO, Holdsworth CD, et al. 1993 Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis. Gut. 34:125-128.
10. Ayres JG, Bateman ED, Lundback B, Harris TAJ. 1995 High dose fluticasone propionate, 1 mg daily, M. fluticasone propionate, 2 mg daily, or budesonide 1.6 mg daily, in patients with chronic severe asthma. International Study Group. Eur Respir J. 84:579-586.
11. Dahl R, Lundback B, Malo JL, et al. 1993 A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest. 104:1352-1358.
12. -1) administered by pressurised inhaler. Respir Med. 87:609-620.
13. Barnes NC, Marone G, Di Maria GU, et al. 1993 A comparsion of fluticasone propionate 1 mg daily with beclomethasone dipropionate 2 mg daily in the treatment of severe asthma. Eur Respir J. 6:877-884.
14. Leblanc P, Mink S, Keistinen T, et al. 1994 A comparsion of fluticasone propionate 200 μg/day with beclomethasone dipropionate 400 μ.g/day in adult asthma. Allergy. 49:380-385.
15. Hoffmann-Streb A, L'Allemand D, Buettner-Goetz P, Wahn U. 1991 Adrenal function in asthmatic children treated with fluticasone or budesonide. J Allergy Clin Immuno. 87(Suppl 1):311.
16. Götz M. 1991 The safety and efficacy of inhaled fluticasone propionate in childhood asthma. Eur Respir J. 4(Suppl 14):404.
17. Clark DJ, Grove A, Cargill RI, Lipworth BJ. 1996 Comparative adrenal suppression with inhaled budesonide and fluticasone propionate in adult asthmatic patients. Thorax. 51:262-266.
18. Clark DJ, Clark RA, Lipworth BJ. 1996 Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children. Thorax. 51:941-943.
19. Clark DJ, Lipworth BJ. 1997 Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients. Thorax. 52:55-58.
20. English AF, Neate MS, Quint DJ, Sareen M. 1994 Biological activities of some corticosteroids used in asthma. Am J Respir Crit Care Med. 149(Suppl):A212.
21. Phillips GH. 1990 Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med. 84(Suppl A):19-23.
22. Wurthwein G, Rehder S, Rohdewald P. 1992 Lipophilicity and receptor affinity of glucocorticoids. Pharm Ztg Wiss. 4:161-167.
23. Hogger P, Rohdewald P. 1994 Binding kinetics of fluticasone propionate to human glucocorticoid receptor. Steroids. 59:597-602.
24. Thorsson L, Dahlstrom K, Edsbacker S, Callen E, Poulson G, Wirren G. 1997 Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects. Br J Clin Pharmacol. 43:155-161.
25. Ng PC, Wong GWK, Lam CWK, et al. 1997 Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopuknonary dysplasia. J Clin Endocrinol Metab. 82:2429-2432.